UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Current Challenges in the Management of Heart Failure

Circulation Journal, 2015/04/24, Vol.79(5), pp.948-953

Komajda, Michel

2015

Link zum Volltext

Verfügbarkeit prüfen

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

The New England journal of medicine, 2021-01, Vol.384 (2), p.117-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

The Lancet (British edition), 2010-09, Vol.376 (9744), p.875-885

2010

Link zum Volltext

Verfügbarkeit prüfen

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

The Lancet (British edition), 2010-09, Vol.376 (9744), p.886-894

2010

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Lancet (British edition), 2009-06, Vol.373 (9681), p.2125-2135

2009

Link zum Volltext

Verfügbarkeit prüfen

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

European heart journal, 2013-07, Vol.34 (28), p.2149-2157

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Torcetrapib in Patients at High Risk for Coronary Events

The New England journal of medicine, 2007-11, Vol.357 (21), p.2109-2122

2007

Link zum Volltext

Verfügbarkeit prüfen

Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

Journal of the American College of Cardiology, 2013-11, Vol.62 (21), p.1977-1985

2013

Link zum Volltext

Verfügbarkeit prüfen

Heart rate and its reduction in chronic heart failure and beyond

European journal of heart failure, 2017-10, Vol.19 (10), p.1230-1241

2017

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

European heart journal, 2005-06, Vol.26 (11), p.1115-1140

2005

Link zum Volltext

Verfügbarkeit prüfen

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Clinical research in cardiology, 2013-01, Vol.102 (1), p.11-22

2013

Link zum Volltext

Verfügbarkeit prüfen

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

The American heart journal, 2013-08, Vol.166 (2), p.240-249.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT

European journal of heart failure, 2016-09, Vol.18 (9), p.1182-1189

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study

European journal of heart failure, 2013-11, Vol.15 (11), p.1296-1303

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)

The American journal of cardiology, 2015-12, Vol.116 (12), p.1890-1897

2015

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

European journal of heart failure, 2010-03, Vol.12 (3), p.239-248

2010

Link zum Volltext

Verfügbarkeit prüfen

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey

European heart journal, 2005-08, Vol.26 (16), p.1653-1659

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)

The American journal of cardiology, 2014-02, Vol.113 (3), p.497-503

2014

Link zum Volltext

Verfügbarkeit prüfen

Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment

Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.1106-1113

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)

ESC Heart Failure, 2023-10, Vol.10 (5), p.2895-2902

2023

Link zum Volltext

Verfügbarkeit prüfen

Aging increases circulating BH2 without modifying BH4 levels and impairs peripheral vascular function in healthy adults

Translational research : the journal of laboratory and clinical medicine, 2021-12, Vol.238, p.36-48

2021

Link zum Volltext

Verfügbarkeit prüfen

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

European journal of heart failure, 2007-06, Vol.9 (6-7), p.684-694

2007

Link zum Volltext

Verfügbarkeit prüfen

From abstract to impact in cardiovascular research: factors predicting publication and citation

European heart journal, 2012-12, Vol.33 (24), p.3034-3045

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 453

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(444)
Mit Volltextzugriff
(438)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(301)
Life Sciences & Biomedicine
(298)
Humans
(286)
Cardiac & Cardiovascular Systems
(251)
Cardiovascular System & Cardiology
(251)
Male
(185)
Female
(181)
Heart Failure
(149)
Aged
(148)
Middle Aged
(138)
Heart Failure - Drug Therapy
(99)
Biological And Medical Sciences
(88)
Medical Sciences
(86)
Heart
(78)
Cardiology. Vascular System
(73)
Adult
(68)
Treatment Outcome
(68)
Heart Failure - Physiopathology
(66)
Heart Failure - Mortality
(61)
Prognosis
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current Challenges in the Management of Heart Failure

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

Heart rate and its reduction in chronic heart failure and beyond

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT

Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey

Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)

Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment

Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)

Aging increases circulating BH2 without modifying BH4 levels and impairs peripheral vascular function in healthy adults

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

From abstract to impact in cardiovascular research: factors predicting publication and citation

Suchergebnisse filtern